510(k) · Cardiovascular

Cardiologs Holter Platform

by Philips France Commercial

Cardiologs Holter Platform is an AI-enabled medical device from Philips France Commercial that the U.S. FDA cleared through 510(k) K250569 on August 6, 2025. Its lead review panel is Cardiovascular and its primary product code is DPS (Electrocardiograph).

See also FDA-cleared AI cardiovascular devices in 2025, all FDA AI clearances in 2025, top cardiovascular AI devices.

Key facts

Submission numberK250569
Pathway510(k)
Date of final decision
Company (FDA list)Philips France Commercial
Lead review panelCardiovascular
Primary product codeDPS — Electrocardiograph
Applicant (openFDA)Philips France Commercial
Applicant locationParis, FR
Device classClass 2
Regulation number21 CFR 870.2340
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. Cardiologs Holter Platform went through this pathway (K250569).

openFDA lists it as a Class 2 device under 21 CFR 870.2340. Class II devices are moderate risk and are subject to general and special controls.

Product code DPS covers 7 devices on the FDA AI list. By decision date, this device is #7 of 7 under that code. Philips France Commercial has 1 AI-enabled device on the list, and the Cardiovascular panel accounts for 154 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code DPS)